Viromed Medical AG / DE000A3MQR65

05.02.2025 - 10:46:11

Viromed Medical AG: Uwe Perbandt, Re-placement of 1,250,000 shares from the holdings of the founder and CEO Uwe Perbandt to a strategic investor. The relevant price for the transaction ...

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

05.02.2025 / 10:45 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name:	Uwe
Last name(s):	Perbandt

2. Reason for the notification

a) Position / status

Position:

Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Viromed Medical AG

b) LEI

894500XR05MYCVCCR171

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A3MQR65

b) Nature of the transaction

Re-placement of 1,250,000 shares from the holdings of the founder and CEO Uwe Perbandt to a strategic investor. The relevant price for the transaction has not yet been determined. It was agreed as the average price of the share in the three months following the conclusion of the contract for the transaction.

c) Price(s) and volume(s)

Price(s)	Volume(s)
not numberable	not numberable

d) Aggregated information

Price	Aggregated volume
not numberable	not numberable

e) Date of the transaction

31/01/2025; UTC+1

f) Place of the transaction

Outside a trading venue

05.02.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com